ARCHIVES

European Compound enhances IL-2 In BRMP Mouse Study; BRMP Mouse Study; Rosemberg Describes System Improvements, Updates Results

This article is from The Cancer Letter archive.

Vol. 13 No. 23 | June 5, 1987

Download PDF Visit The Full Archive

Related Articles

Memorial’s Scher Warns FDA About Flaws In Provenge Data, Urges Not To Approve.

April 13, 2007

NCI’s Rosenberg Confirms 2002 Immunotherapy Results

April 29, 2005

DCT Concepts Approved

October 11, 1985

Expert Review Of ImClone Protocol Concludes C225 Approval Unlikely.

February 15, 2002

ACS Board To Consider Proposal For Implementing Cancer Response System Nationwide; Could End CIS

June 7, 1985

Iniparib Plus Chemo Shows Benefit In Phase II Study

January 28, 2011